The RFS and median OS of patients in the previous study were 30% and 58 months, respectively, which were lower than those reported in this study
The overlap between OA and metabolic dysfunction prompted scientists to propose that OA might be a component of the metabolic syndrome [4,5]
In future, the researchers may use the information listed in this review as a clue to deeply understand the bioactive compounds in these herbal medicines for alleviating APAP-induced hepatoxicity, and their mechanisms of action
Understanding the perspectives of leading scientists helps provide a balanced view of where this research currently stands and where it might be headed
For products like semaglutide injection, FDA guidance stipulates Q1/Q2 sameness of excipients for a bioequivalence waiver
When GLP-1 medications further slow stomach emptying, digestive symptoms may temporarily intensify during dose escalation